Skip to main content
    E

    Elevai Labs, Inc. Common Stock (ELAB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.00
    +0.03 (+0.84%)

    Market Cap: $2.40M

    Last updated: Oct 16, 2026 at 1:55 PM ET

    Earnings

    PeriodReportedEst.SurpriseB/MYoY
    Jun 26
    Reported Aug 14
    		$-0.61N/AN/ABeat+92.8%
    Mar 26
    Reported May 14
    		$-111.75N/AN/ABeat-3753.4%
    Dec 25
    Reported Mar 26
    		$-519.17N/AN/ABeat-447.4%
    Sep 25
    Reported Nov 14
    		$-4.95N/AN/ABeat+100.0%
    Jun 25
    Reported Aug 12
    		$-8.44$0.00N/AMiss+100.0%
    Mar 25
    Reported Apr 4
    		$-2.90N/AN/ABeat+100.0%
    Sep 24
    Reported Nov 13
    		$-94.85N/AN/ABeat-
    Jun 24
    Reported Aug 14
    		$-90777.00N/AN/ABeat-
    Mar 24
    Reported May 15
    		$-94818.36N/AN/ABeat-
    Dec 23
    Reported Mar 29
    		$-78576.99N/AN/ABeat-

    Key Metrics

    Valuation
    P/E Ratio-0.00EV/EBITDAN/A
    Price/FCF-0.16xFCF Yield-618.99%
    Profitability
    Profit Margin0.00%Operating Margin-290.00%
    ROE-105.20%ROIC-30.69%
    Financial Health
    Debt/Equity0.56xInterest Coverage-7.77x
    Current Ratio1.36xQuick Ratio1.30x
    Trading Statistics
    Beta-0.27Avg Volume51.05K
    52-Week High$1823.0452-Week Low$2.58

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$3.12
    SMA 20$3.68
    SMA 50$5.31
    SMA 200$53.11
    EMA 10$3.20
    EMA 20$3.66
    EMA 50$6.14
    EMA 200$239.88

    MACD

    Line: -0.70Signal: -0.76Hist: 0.06

    ADX

    ADX: 22.3+DI: 8.6-DI: 15.4

    Aroon & PSAR

    Aroon Up48.0
    Aroon Down60.0
    PSAR$6.31

    Bollinger Bands

    Upper Band$5.06
    Lower Band$2.30
    %B Position7505%(Upper)
    Band Width0.25

    RSI (14-Day)

    Oversold
    24.6

    Momentum Oscillators

    Stoch %K13.1
    Stoch %D13.9
    Williams %R-86.2
    ROC (10d)-7.1%
    Momentum-0.23
    CCI (20d)-78.1
    MFI (14d)40.8

    Volatility Measures

    ATR (14d)$0.82(27.5%)
    StdDev (20d)0.69
    Hist Vol98.7%(High)

    Volume Flow

    VWAP$2.94
    OBV464.5M
    AD Line1163.0B
    CMF (20d)-0.226

    Volume Metrics

    Avg Vol (20d)54.8K
    Vol Ratio0.3x(Low)
    VWMA (20d)$3.99

    Pivot Points

    R3$3.15
    R2$3.11
    R1$3.04
    Pivot Point$3.00
    S1$2.93
    S2$2.89
    S3$2.82

    Advanced Oscillators

    TSI-49.08
    Ultimate Osc37.2
    KST-382.53

    Financial Data

    QuarterJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023
    Total Revenue$1.31M$681,994$18,188$571,896$0$0$-1,747,570$0$0$0$-1,014,004$554,654
    Cost of Revenue$920,919$453,087$-115,727$520,497$0$0$590,819$0$0$0$-341,122$188,509
    Gross Profit$385,691$230,474$107,284$78,030$0$0$-1,747,570$0$0$0$-672,882$366,145
    Operating Expenses$4.09M$3.55M$2.24M$1.96M$1.01M$1.07M$1.68M$626,606$556,054$798,181$-2,223,804$1.15M
    R&D$310,219$47,061$32,902$15,000$66,675$32,433$62,950$4,098$34,824$2,782$-296,359$86,374
    SG&A$2.16M$1.97M$1.47M$1.12M$604,014$475,499$941,511$341,511$197,047$175,749$-1,599,062$808,576
    Operating Income$-3,706,946$-3,318,643$-1,818,649$-2,198,901$-1,014,401$-1,071,725$-1,677,870$-625,615$-556,054$-798,181$1.55M$-785,551
    Interest Income$146,400$86,072$19,450$30,181$134,727$-437,822$12,646$95$64$86$2,719$25
    Interest Expense$582,241$474,170$50,274$196,880$2$10,474$50,621$641,807$23,597$19,172$64,060$5,713
    Income Before Tax$-2,758,425$-4,461,933$-1,603,733$-2,330,070$-579,490$-1,580,811$-1,718,820$-1,200,862$-552,911$-544,121$1.49M$-779,934
    Income Tax Expense$0$0$0$0$0$0$0$0$0$0$0$0
    Net Income$-2,941,382$-4,967,259$-3,329,035$-2,308,372$-562,355$-1,608,455$-1,934,739$-1,501,257$-1,412,491$-1,397,250$-1,157,916$-783,047
    EBITDA$-2,017,181$-3,899,931$-1,223,030$-2,418,209$-714,194$-1,130,914$-1,677,610$-555,912$-544,089$-503,847$1.48M$-771,334
    EBIT$-2,322,584$-4,073,835$-1,282,787$-2,453,493$-714,215$-1,132,515$-1,680,845$-559,150$-529,378$-525,035$1.47M$-774,246
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ELAB

    News

    PMGC Holdings Inc. has Changed its Name to NorthStrive Holdings, Inc

    PMGC Holdings Inc. has officially changed its name to NorthStrive Holdings, Inc. This change was published on October 8, 2026, at 10:01 am EDT, and reflects an update in the company's corporate identity. The company...

    www.marketscreener.com•10/9/26•Neutral

    PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update

    PMGC Holdings Inc. announced that it has registered "NorthStrive Holdings, Inc." as a doing-business-as (DBA) name and entered into a Trademark License Agreement with NorthStrive Companies Inc. This allows PMGC Holdings...

    markets.businessinsider.com•10/8/26•Somewhat-Bullish

    PMGC Holdings adopts NorthStrive brand name via DBA registration

    PMGC Holdings Inc. has registered a doing-business-as (DBA) name of NorthStrive Holdings, Inc. and entered into a Trademark License Agreement for the NorthStrive brand. This move is the first step in a broader...

    StreetInsider•10/8/26•Somewhat-Bullish

    PMGC Holdings Inc. Announces DBA as NorthStrive Holdings,

    PMGC Holdings Inc. has announced it will operate under the doing-business-as (DBA) name NorthStrive Holdings, Inc., effective immediately...

    GlobeNewswire•10/8/26•Somewhat-Bullish

    PMGC Holdings Inc. Announces DBA as NorthStrive Holdings, Inc., Trademark License Agreement, and Website Update

    PMGC Holdings Inc. has announced the registration of a doing-business-as (DBA) name as NorthStrive Holdings, Inc. and has entered into a Trademark License Agreement with NorthStrive Companies Inc. This rebranding effort...

    Yahoo Finance•10/8/26•Neutral

    ELAB Valuation and Fair Value

    P/E
    -0.0x
    P/FCF
    -0.2x
    P/B
    0.1x
    See GNG's fair value

    ELAB Profitability: Margins, ROIC and FCF

    Gross margin
    31.1%
    Operating margin
    -290.0%
    Net margin
    0.0%
    ROIC
    -30.7%
    ROE
    -105.2%
    FCF margin
    -350.6%
    FCF yield
    -619.0%

    ELAB Competitors

    CompanyTicker
    GeoVax Labs IncGOVX
    Flora Growth CorpFLGC
    Matinas BioPharma Holdings IncMTNB
    Virax Biolabs Group Limited Ordinary SharesVRAX
    Kairos Pharma, Ltd.KAPA
    Scisparc LtdSPRC
    Biomotion Sciences Ordinary SharesSLXN
    Nuwellis IncNUWE

    Sector: Healthcare

    ELAB Bull Case vs Bear Case

    Bear case

    • ELAB's quarterly revenue changed -45.8% year over year.

    Frequently Asked Questions About ELAB

    Does ELAB pay dividends?

    Elevai Labs, Inc. Common Stock (ELAB) does not currently pay a regular dividend.

    What is ELAB's market cap?

    Elevai Labs, Inc. Common Stock (ELAB) has a market capitalization of $2.40M with a current stock price of $3.00.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In